The global intragastric balloon market size is expected to increase USD 108.8 million by 2033 from USD 45 million in 2023 with a CAGR of 9.22% between 2024 and 2033.
Key Points
- By region, North America held the largest share of the intragastric balloon market in 2023 with 38.4%.
- By region, Asia Pacific is expected to witness significant growth during the forecast period.
- By balloon type, in 2023, the single segment held the largest share of 66%.
- By filling material, the saline filled segment held the dominant share of around 73% in 2023.
- By administration, the endoscopy segment held the largest share of over 72.3% in 2023.
- By end use, the hospitals segment has accounted market share of around 55% in 2023.
The intragastric balloon market focuses on the use of intragastric balloons as a non-surgical, temporary weight loss solution for obese and overweight individuals. Intragastric balloons are soft, expandable devices placed inside the stomach using minimally invasive endoscopic procedures. Once inflated, the balloon occupies space in the stomach, reducing its capacity for food intake and promoting a feeling of fullness. This helps patients control their calorie intake and lose weight over a period of time.
In recent years, the intragastric balloon market has experienced significant growth due to the rising prevalence of obesity worldwide and the increasing preference for non-surgical weight loss solutions. The market is characterized by a variety of intragastric balloon products, including saline-filled and gas-filled balloons, with different sizes and capacities tailored to meet individual patient needs.
Get a Sample: https://www.precedenceresearch.com/sample/4081
Growth Factors:
- Rising Prevalence of Obesity: The global increase in obesity rates has driven the demand for effective weight loss solutions such as intragastric balloons. As obesity is associated with numerous health risks, including diabetes and cardiovascular diseases, more individuals are seeking non-surgical options for weight management.
- Advancements in Medical Technology: Innovations in intragastric balloon design and materials have made the procedures safer and more effective. Improved endoscopic techniques have enhanced the precision of balloon placement, contributing to the market’s growth.
- Growing Awareness of Minimally Invasive Procedures: As more patients and healthcare professionals recognize the benefits of minimally invasive procedures, the demand for intragastric balloons as a weight loss option increases.
- Government Initiatives: Several governments and health organizations are focusing on combating obesity through various programs and initiatives. These efforts promote awareness of weight loss options, including intragastric balloons.
Region Insights:
- North America: This region dominates the intragastric balloon market due to high obesity rates, well-established healthcare infrastructure, and advanced medical technology. The United States is a major market within North America.
- Europe: Europe also holds a significant share in the market, driven by increasing awareness of obesity-related health risks and the availability of minimally invasive weight loss procedures.
- Asia-Pacific: This region is expected to witness substantial growth due to rising obesity rates, increasing healthcare expenditure, and a growing middle-class population with disposable income to spend on health and wellness.
- Latin America and Middle East & Africa: These regions are emerging markets with increasing demand for intragastric balloons as awareness of the procedure and obesity-related health risks rises.
Intragastric Balloon Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 9.22% |
| Global Market Size in 2023 | USD 45 Million |
| Global Market Size in 2024 | USD 49.15 Million |
| Global Market Size by 2033 | USD 108.8 Million |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Balloon Type, By Filling Material, By Administration, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Intragastric Balloon Market Dynamics
Drivers:
- Growing Demand for Non-Surgical Weight Loss Options: Patients are increasingly looking for less invasive weight loss solutions, and intragastric balloons offer a safe and effective alternative to surgery.
- Improving Healthcare Infrastructure: As healthcare systems in emerging economies improve, access to intragastric balloon procedures increases, driving market growth.
- Technological Advancements: New materials and designs for intragastric balloons have improved the safety and effectiveness of the procedure, contributing to market expansion.
- Supportive Reimbursement Policies: In some regions, insurance coverage for intragastric balloon procedures has become more common, making the option more accessible to patients.
Opportunities:
- Expansion into Emerging Markets: As awareness of obesity and weight loss options grows in emerging markets, there is potential for expansion in these regions.
- Development of Innovative Products: Ongoing research and development in intragastric balloon technology can lead to new products with enhanced safety and efficacy.
- Collaboration with Healthcare Providers: Partnerships with healthcare providers and clinics can help expand the reach of intragastric balloon procedures.
- Patient Education: Educating patients about the benefits and risks of intragastric balloons can increase adoption rates and drive market growth.
Challenges:
- Regulatory Hurdles: Intragastric balloons are subject to stringent regulations in many regions, which can slow down product approvals and market entry.
- Safety Concerns: Although intragastric balloons are generally considered safe, there have been reports of complications such as balloon deflation, migration, and gastrointestinal perforation. Ensuring patient safety is essential for market growth.
- High Costs: The cost of intragastric balloon procedures can be a barrier for some patients, particularly in regions where insurance coverage is limited.
- Competition from Alternative Weight Loss Methods: Other weight loss options, such as pharmacological treatments and bariatric surgery, may compete with intragastric balloons for market share.
Read Also: Cellular Health Screening Market Size, Share, Report by 2033
Recent Developments
- In September 2022, Allurion Technologies, the United States-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India.
Intragastric Balloon Market Companies
- Allurion Technologies
- Allergan (Acquired by Abbott)
- Apollo Endosurgery
- Reshape Medical
- Spatz FGIA
- Endalis
- Silimed
- Medsil
Segment Covered in the Report
By Balloon Type
- Single
- Dual
- Triple
By Filling Material
- Saline Filled
- Gas Filled
By Administration
- Endoscopy
- Pill Form
By End-use
- Hospitals
- Ambulatory Centers
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
